Cargando…
Can the Market Recognize the Value of the Corporate Governance Mechanism of Chinese Listed Companies?—Empirical Evidence From COVID-19
This paper studies whether the market can recognize the value of corporate governance mechanisms (ownership structure, board structure, and managerial incentives) of Chinese listed companies. We find that when companies are faced with “black swan” events, such as COVID-19, non-state-owned enterprise...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826234/ https://www.ncbi.nlm.nih.gov/pubmed/35155358 http://dx.doi.org/10.3389/fpubh.2021.812253 |
_version_ | 1784647389907255296 |
---|---|
author | Li, Jianwei Ma, Yunbiao Shi, Beibei Yang, Yi |
author_facet | Li, Jianwei Ma, Yunbiao Shi, Beibei Yang, Yi |
author_sort | Li, Jianwei |
collection | PubMed |
description | This paper studies whether the market can recognize the value of corporate governance mechanisms (ownership structure, board structure, and managerial incentives) of Chinese listed companies. We find that when companies are faced with “black swan” events, such as COVID-19, non-state-owned enterprise are found to be more valuable, that is, the stock price of non-state-owned enterprises are more immune to the negative shocks of COVID-19. For board structure, the arrangement of the duality of chairman and CEO is found to be more valuable and can effectively alleviate the negative shocks of the epidemic on the stock price. For managerial incentives mechanisms, it shows that management shareholding, management compensation, and executive stock options are all effective mechanisms and can better withstand the negative shocks of the COVID-19 epidemic on the stock price of companies. This paper sheds light on the value of corporate governance mechanisms in the Chinese capital market from the perspective of investors, which enriches literature in the field of corporate governance. |
format | Online Article Text |
id | pubmed-8826234 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88262342022-02-10 Can the Market Recognize the Value of the Corporate Governance Mechanism of Chinese Listed Companies?—Empirical Evidence From COVID-19 Li, Jianwei Ma, Yunbiao Shi, Beibei Yang, Yi Front Public Health Public Health This paper studies whether the market can recognize the value of corporate governance mechanisms (ownership structure, board structure, and managerial incentives) of Chinese listed companies. We find that when companies are faced with “black swan” events, such as COVID-19, non-state-owned enterprise are found to be more valuable, that is, the stock price of non-state-owned enterprises are more immune to the negative shocks of COVID-19. For board structure, the arrangement of the duality of chairman and CEO is found to be more valuable and can effectively alleviate the negative shocks of the epidemic on the stock price. For managerial incentives mechanisms, it shows that management shareholding, management compensation, and executive stock options are all effective mechanisms and can better withstand the negative shocks of the COVID-19 epidemic on the stock price of companies. This paper sheds light on the value of corporate governance mechanisms in the Chinese capital market from the perspective of investors, which enriches literature in the field of corporate governance. Frontiers Media S.A. 2022-01-26 /pmc/articles/PMC8826234/ /pubmed/35155358 http://dx.doi.org/10.3389/fpubh.2021.812253 Text en Copyright © 2022 Li, Ma, Shi and Yang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Public Health Li, Jianwei Ma, Yunbiao Shi, Beibei Yang, Yi Can the Market Recognize the Value of the Corporate Governance Mechanism of Chinese Listed Companies?—Empirical Evidence From COVID-19 |
title | Can the Market Recognize the Value of the Corporate Governance Mechanism of Chinese Listed Companies?—Empirical Evidence From COVID-19 |
title_full | Can the Market Recognize the Value of the Corporate Governance Mechanism of Chinese Listed Companies?—Empirical Evidence From COVID-19 |
title_fullStr | Can the Market Recognize the Value of the Corporate Governance Mechanism of Chinese Listed Companies?—Empirical Evidence From COVID-19 |
title_full_unstemmed | Can the Market Recognize the Value of the Corporate Governance Mechanism of Chinese Listed Companies?—Empirical Evidence From COVID-19 |
title_short | Can the Market Recognize the Value of the Corporate Governance Mechanism of Chinese Listed Companies?—Empirical Evidence From COVID-19 |
title_sort | can the market recognize the value of the corporate governance mechanism of chinese listed companies?—empirical evidence from covid-19 |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826234/ https://www.ncbi.nlm.nih.gov/pubmed/35155358 http://dx.doi.org/10.3389/fpubh.2021.812253 |
work_keys_str_mv | AT lijianwei canthemarketrecognizethevalueofthecorporategovernancemechanismofchineselistedcompaniesempiricalevidencefromcovid19 AT mayunbiao canthemarketrecognizethevalueofthecorporategovernancemechanismofchineselistedcompaniesempiricalevidencefromcovid19 AT shibeibei canthemarketrecognizethevalueofthecorporategovernancemechanismofchineselistedcompaniesempiricalevidencefromcovid19 AT yangyi canthemarketrecognizethevalueofthecorporategovernancemechanismofchineselistedcompaniesempiricalevidencefromcovid19 |